TW202304546A - Microneedle structure production method and microneedle structure - Google Patents
Microneedle structure production method and microneedle structure Download PDFInfo
- Publication number
- TW202304546A TW202304546A TW111112637A TW111112637A TW202304546A TW 202304546 A TW202304546 A TW 202304546A TW 111112637 A TW111112637 A TW 111112637A TW 111112637 A TW111112637 A TW 111112637A TW 202304546 A TW202304546 A TW 202304546A
- Authority
- TW
- Taiwan
- Prior art keywords
- water
- needle
- microneedle structure
- base material
- aforementioned
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 112
- 239000002195 soluble material Substances 0.000 claims abstract description 95
- 239000002198 insoluble material Substances 0.000 claims abstract description 84
- 239000007788 liquid Substances 0.000 claims abstract description 72
- 239000000203 mixture Substances 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000035699 permeability Effects 0.000 claims abstract description 9
- 239000000758 substrate Substances 0.000 claims description 81
- 239000002904 solvent Substances 0.000 claims description 25
- 210000001124 body fluid Anatomy 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 9
- 239000013543 active substance Substances 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 239000002759 woven fabric Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 239000002657 fibrous material Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 description 28
- 239000011347 resin Substances 0.000 description 28
- 238000010438 heat treatment Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- 238000007689 inspection Methods 0.000 description 14
- 239000010839 body fluid Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000011148 porous material Substances 0.000 description 11
- 239000012790 adhesive layer Substances 0.000 description 10
- 229920006167 biodegradable resin Polymers 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- -1 polybutylene succinate Polymers 0.000 description 9
- 238000007872 degassing Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 239000002313 adhesive film Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 210000003722 extracellular fluid Anatomy 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000008247 solid mixture Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 239000004632 polycaprolactone Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229920005992 thermoplastic resin Polymers 0.000 description 4
- 238000004506 ultrasonic cleaning Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 238000010030 laminating Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 238000009210 therapy by ultrasound Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 239000013335 mesoporous material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920002961 polybutylene succinate Polymers 0.000 description 1
- 239000004631 polybutylene succinate Substances 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000013464 silicone adhesive Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150969—Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/685—Microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/12—Manufacturing methods specially adapted for producing sensors for in-vivo measurements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
本發明係關於微針構造體的製造方法及微針構造體者。The present invention relates to a method for producing a microneedle structure and a microneedle structure.
近年來,已提案通過形成於微針之貫通孔而進行對體內供給藥劑、從體內採取體液等。例如,作為進行對體內供給藥劑之物質的擴散性優異之微針,已知以下者:高度為20μm以上且小於500μm,高度h與底邊的最大長度a的縱橫比(h/a)為2以上,且由介孔材料所構成者(專利文獻1)。又,為了更正確地掌握患者的症狀等,提案有一種對身體的負擔小之分析貼片,其將長度小於1毫米的微小的微針刺於患者的皮膚而進行採血,並分析此血液。專利文獻2中,公開下述者作為患者自己可簡便且持續地進行血糖監測之低侵入性的檢查貼片:將形成有微通道之底板作為基材,在該底板上,將用於形成針狀部之黏性材料從分配器緩緩吐出而形成多個針狀部。此檢查貼片係將針狀部刺於患者,從底板所設之微通道的毛細管泵部,藉由毛細管現象,持續地從針狀部採取血液,並利用底板所設之反應室中之感測器而測量採取到的血液。
[先行技術文獻] [專利文獻]
In recent years, it has been proposed to supply drugs into the body, collect body fluids from the body, and the like through through holes formed in microneedles. For example, microneedles having a height of 20 μm or more and less than 500 μm and an aspect ratio (h/a) of height h to the maximum length a of the bottom side of 2 are known as microneedles excellent in diffusibility of substances for supplying drugs to the body. The above, and those made of mesoporous materials (Patent Document 1). In addition, in order to understand the patient's symptoms more accurately, an analysis patch with a small burden on the body is proposed, which uses tiny microneedles with a length of less than 1 mm to pierce the patient's skin to collect blood and analyze the blood. In
[專利文獻1]日本專利特開2014-094171號公報 [專利文獻2]WO2019/176126號公報 [Patent Document 1] Japanese Patent Laid-Open No. 2014-094171 [Patent Document 2] WO2019/176126 Publication
[發明所欲解決的問題][Problem to be solved by the invention]
上述檢查貼片所使用之底板,需要在板上形成細微的毛細管泵部、微通道等,但期望更便宜且簡便地製作確保通道之檢查貼片、微針構造體等。又,即使為藉由簡便的方法所製作之檢查貼片等,亦必須為可如同預期地形成針狀部的形狀並確保通道者。It is necessary to form fine capillary pump parts, microchannels, etc. on the substrate used in the above-mentioned inspection patch, but it is desired to manufacture inspection patches, microneedle structures, etc. that ensure channels more cheaply and easily. Moreover, even if it is an inspection patch etc. produced by a simple method, it must form the shape of acicular part as expected and ensure a channel.
本發明係鑑於此種實際狀況而完成者,其目的在於提供可簡便地獲得確保通道之微針構造體之微針構造體及該微針構造體的製造方法。 [用以解決問題的手段] The present invention has been made in view of such actual situation, and an object of the present invention is to provide a microneedle structure capable of easily obtaining a microneedle structure securing channels and a method for manufacturing the microneedle structure. [means used to solve a problem]
為了達成上述目的,第一,本發明提供一種微針構造體的製造方法,其係在於厚度方向具有液體穿透性之基材的一面側具備具有孔部的針狀部之微針構造體的製造方法,其特徵在於,包含:形成步驟,其使用含有第一水不溶性材料及第一水溶性材料之針狀部形成用的組成物而形成突起部;接著步驟,其使前述組成物或在前述形成步驟中所形成之前述突起部與前述基材進行接著;以及去除步驟,其使前述突起部與前述基材浸漬於水中,溶解並去除前述第一水溶性材料,藉此從前述突起部形成前述針狀部及前述孔部(發明1)。In order to achieve the above object, first, the present invention provides a method of manufacturing a microneedle structure, which is a microneedle structure having a needle-shaped portion having a hole on one side of a substrate having liquid permeability in the thickness direction. The manufacturing method is characterized by comprising: a forming step of forming protrusions using a needle-shaped portion-forming composition containing a first water-insoluble material and a first water-soluble material; and a subsequent step of making the aforementioned composition or The aforementioned protrusion formed in the aforementioned forming step is bonded to the aforementioned substrate; and a removing step of immersing the aforementioned protrusion and the aforementioned substrate in water to dissolve and remove the aforementioned first water-soluble material, thereby removing the aforementioned protrusion from the aforementioned Forming the aforementioned needle-like portion and the aforementioned hole portion (Invention 1).
在上述發明(發明1)中,因使用於厚度方向具有液體穿透性之基材,故可簡便地在微針構造體形成通道。而且,因在將此種基材與組成物或在形成步驟中所形成之前述突起部進行接著後,在去除步驟中在突起部形成孔部,故突起部的孔部與基材中之孔部容易連結,容易在微針構造體形成通道。In the above invention (Invention 1), since a substrate having liquid permeability in the thickness direction is used, channels can be easily formed in the microneedle structure. Moreover, after bonding such a base material and the composition or the above-mentioned protrusions formed in the forming step, holes are formed in the protrusions in the removal step, so the holes of the protrusions and the holes in the base material The parts are easy to connect, and it is easy to form a channel in the microneedle structure.
在上述發明(發明1)中,較佳為前述於厚度方向具有液體穿透性之基材為多孔性的基材,前述接著步驟為使由前述形成步驟所形成之前述突起部與包含第二水溶性材料及前述多孔性的基材之片進行接著之步驟,前述去除步驟為溶解並去除前述第一水溶性材料及第二水溶性材料之步驟(發明2)。In the above invention (Invention 1), it is preferable that the base material having liquid permeability in the thickness direction is a porous base material, and the subsequent step is to combine the protrusion formed by the forming step with the second The sheet of the water-soluble material and the aforementioned porous substrate is subjected to the next step, and the aforementioned removing step is a step of dissolving and removing the aforementioned first water-soluble material and the second water-soluble material (invention 2).
藉由多孔性的基材含有第二水溶性材料,在將基材與所形成之突起部進行接著之情形中,可抑制基材吸收突起部的組成物。其結果,因在突起部亦即針狀部的特別是根部未形成過多空隙,故抑制針狀部崩塌,並可形成具有適於與成為通道之基材進行接著的形狀之針狀部,而可製造針狀部與基材的接著良好之微針構造體。When the porous base material contains the second water-soluble material, when the base material is bonded to the formed protrusions, the base material can be suppressed from absorbing the composition of the protrusions. As a result, since the protruding portion, that is, the needle-shaped portion, especially the root portion, does not form too many voids, the collapse of the needle-shaped portion is suppressed, and the needle-shaped portion having a shape suitable for bonding to the base material that becomes the channel can be formed, and A microneedle structure with good adhesion between the acicular part and the substrate can be produced.
在上述發明(發明2)中,較佳為前述多孔性的基材係由纖維狀物質所構成之基材(發明3)。In the above invention (Invention 2), it is preferable that the porous substrate is a substrate composed of a fibrous substance (Invention 3).
在上述發明(發明2、3)中,較佳為前述片包含第二水不溶性材料(發明4)。In the above inventions (
在上述發明(發明4)中,較佳為前述第一水不溶性材料與前述第二水不溶性材料相同(發明5)。In the above invention (Invention 4), it is preferable that the first water-insoluble material is the same as the second water-insoluble material (Invention 5).
在上述發明(發明2~5)中,較佳為前述片係使前述基材含浸第二水溶性材料而成者(發明6)。In the above inventions (
在上述發明(發明2~6)中,較佳為前述由纖維狀物質所構成之基材為不織布、紡織物、針織物或紙(發明7)。In the above inventions (
在上述發明(發明1)中,較佳為前述基材係由具有液體不穿透性之材料所構成之基材,並且,具有沿著厚度方向形成之貫通孔(發明8)。In the above invention (Invention 1), it is preferable that the base material is made of a liquid-impermeable material and has through-holes formed along the thickness direction (Invention 8).
藉由基材具有液體不穿透性,因可抑制基材的液體吸收,故液體在基材中可僅通過沿著厚度方向形成之貫通孔內。因此,從針狀部所得之體液或輸送往針狀部之藥液不會在基材內滲出,可使全部的量透過貫通孔進行流通。而且,因在將此種基材與組成物或由形成步驟所形成之前述突起部進行接著後,在去除步驟中在突起部形成孔部,故突起部的孔部與基材中之貫通孔容易連結,容易在微針構造體形成通道。Since the base material has liquid impermeability, since the liquid absorption of the base material can be suppressed, the liquid can only pass through the through-holes formed along the thickness direction in the base material. Therefore, the body fluid obtained from the needle-shaped part or the liquid medicine delivered to the needle-shaped part does not seep out of the substrate, and the entire amount can be circulated through the through-hole. Moreover, after bonding such a base material and the composition or the above-mentioned protrusions formed in the forming step, holes are formed in the protrusions in the removing step, so the holes of the protrusions and the through-holes in the base material Easy to connect, easy to form channels in the microneedle structure.
在上述發明(發明1~8)中,較佳為包含:填充步驟,其將前述針狀部形成用的組成物填充至具有凹部之模具(發明9)。In the above-mentioned inventions (
在上述發明(發明9)中,較佳為前述填充步驟中,前述針狀部形成用的組成物包含溶劑,前述形成步驟中,使前述溶劑蒸發(發明10)。In the above invention (Invention 9), preferably, in the filling step, the composition for forming the needle-like portion contains a solvent, and in the forming step, the solvent is evaporated (Invention 10).
在上述發明(發明1~10)中,較佳為具有:設置步驟,其在前述基材之與設有前述針狀部的面相反的面側,設置體液的分析手段及/或生理活性物質的儲存手段(發明11)。In the above inventions (
第二,本發明提供一種微針構造體,其係在多孔性的基材的一面側具備具有孔部的針狀部之微針構造體,其特徵在於,前述針狀部係由第一水不溶性材料所構成,並且直接設於前述多孔性的基材,前述多孔性的基材含有第二水不溶性材料(發明12)。 [發明功效] Second, the present invention provides a microneedle structure having an acicular portion having a hole on one side of a porous substrate, wherein the acicular portion is formed of a first water It is composed of an insoluble material, and is directly provided on the aforementioned porous substrate, and the aforementioned porous substrate contains a second water-insoluble material (Invention 12). [Efficacy of the invention]
根據本發明的微針構造體的製造方法,可提供一種微針構造體,其可簡便地獲得確保通道之針狀部,且同時以所期望的形狀形成針狀部,並且,針狀部與通道的接合良好。According to the manufacturing method of the microneedle structure of the present invention, it is possible to provide a microneedle structure in which the needle-shaped portion ensuring the channel can be easily obtained, and at the same time the needle-shaped portion can be formed in a desired shape, and the needle-shaped portion and Channel engagement is good.
[用以實施發明的形態][Mode for Carrying Out the Invention]
以下,針對本發明的實施形態進行說明。
[微針構造體] 圖1中表示本發明的一實施形態之微針構造體10。微針構造體10具備在基材11的一面側以指定的間隔互相分離之多個針狀部12。微針構造體10可被利用作為:透過針狀部12而從皮膚內吸收間質液並使用所得之間質液進行檢查之檢查貼片;從基材11透過針狀部12而將藥劑從皮膚投予至體內之藥劑投予貼片等。
Embodiments of the present invention will be described below.
[Microneedle structure] Fig. 1 shows a
(1)針狀部 針狀部12的形狀、大小、形成間隔、形成數量等,可依據作為其目的之微針的用途等而適當選擇。作為針狀部12的形狀,可列舉圓柱狀、角柱狀、圓錐狀、角錐狀等,在本實施形態中為角錐狀。針狀部12的最大直徑或剖面的最大尺寸可列舉例如25~1000μm,前端直徑或前端的剖面的尺寸可列舉1~100μm,針狀部12的高度可列舉例如50~2000μm。再者,針狀部12係在基材11的一方向設置多行,且同時在各行形成多個,而配置成矩陣狀。(1) Needle-shaped portion The shape, size, formation interval, formation number, etc. of the needle-
針狀部12係由第一水不溶性材料所構成,所述第一水不溶性材料不溶於在後述之去除步驟中所使用之清洗液所含的水。若考慮製造步驟的處理容易性,則第一水不溶性材料較佳為水不溶性樹脂。水不溶性樹脂較佳為其熔點為高於常溫且250℃以下之水不溶性樹脂,更佳為其熔點為高於40℃且200℃以下之水不溶性樹脂,特佳為其熔點為高於45℃且150℃以下之水不溶性樹脂,特佳為其熔點為高於45℃且80℃以下之水不溶性樹脂。藉由熔點高於常溫,而在常溫中,該水不溶性樹脂會成為固體而可形成針狀部12,又,若熔點低於150℃,則可使用作為基材之材質的選擇的自由度增加,且同時作業性亦提升。The needle-
又,此種水不溶性樹脂,較佳為難以對人體造成影響之水不溶性的生物分解性樹脂。作為生物分解性樹脂,較佳使用脂肪族聚酯及其衍生物,再者,可列舉選自由聚乳酸、聚乙醇酸、聚己內酯、及將構成其等之單體彼此進行共聚合而成之共聚物等所組成之群組的至少1種。又,亦可使用聚丁二酸丁二醇酯、脂肪族芳香族共聚酯、聚羥基丁酸酯等生物分解性樹脂。又,亦可使用此等生物分解性樹脂的二種以上的混合物。最佳為,第一水不溶性材料係熔點為60℃之生物分解性樹脂亦即聚己內酯、或己內酯與構成其他生物分解性樹脂之單體的共聚物。水不溶性樹脂的分子量通常為5,000~300,000,較佳為7,000~200,000,更佳為8,000~150,000。In addition, such a water-insoluble resin is preferably a water-insoluble biodegradable resin that hardly affects the human body. As the biodegradable resin, it is preferable to use aliphatic polyester and its derivatives. Furthermore, examples include polylactic acid, polyglycolic acid, polycaprolactone, and copolymers of monomers constituting them. At least one of the group consisting of copolymers and the like. In addition, biodegradable resins such as polybutylene succinate, aliphatic aromatic copolyester, and polyhydroxybutyrate can also be used. Also, a mixture of two or more of these biodegradable resins may be used. Most preferably, the first water-insoluble material is polycaprolactone, which is a biodegradable resin with a melting point of 60° C., or a copolymer of caprolactone and monomers constituting other biodegradable resins. The molecular weight of the water-insoluble resin is usually 5,000-300,000, preferably 7,000-200,000, more preferably 8,000-150,000.
各針狀部12在其表面及內部形成有孔部13。孔部13係在後述之去除步驟中去除第一水溶性材料所形成者,體液、藥液等會通過此孔部13。孔部13係作為多孔結構而形成於針狀部12。若以成為多孔結構之方式形成針狀部12,則在其內部相對地形成體液或藥液會通過之通道以作為孔部13,因此不需要機械性地形成奈米級的通道而較佳。又,體液或藥液因可通過針狀體中形成有多孔結構之部分的整體,故比起單純的連通孔,能增加流通量。再者,如此以成為多孔結構之方式形成針狀部12之情形,若多孔結構未覆蓋針狀部的側面的一部分或全部,則孔部13亦會在針狀部12的側面開口。此情形,比起只在針狀部12的前端部開口之情形,可增加液體的流通量。孔部13如其剖面所示,依據所形成之孔部13係延伸設置至基材11側為止。孔部13雖依據使用微針構造體10之檢查貼片等的用途而規定其開口的大小,但由容易使液體穿透等之觀點而言,其開口的尺寸較佳為0.1~50.0μm,更佳為0.5~25.0μm,再佳為1.0~10.0μm。此外,在本發明中,所謂體液,係包含血液、淋巴液、間質液等。Each needle-
(2)基材 基材11只要為於厚度方向具有液體穿透性者則未被特別限定。基材11較佳為在內部形成有從一面貫通至另一面側之微小的基材孔部之多孔性的材料。作為此種多孔性的基材11,可使用習知的基材,可列舉例如,由發泡聚氨酯樹脂等發泡材料、多孔性陶瓷等多孔質材料所構成之基材、或者由纖維狀物質所構成之基材。多孔性的基材11通常不溶於水,或由難溶於水的材料所形成。較佳為由容易處理的纖維狀物質所構成之基材。於此,本發明中之所謂纖維狀物質,意指天然纖維、化學纖維等纖維。作為由纖維狀物質所構成之基材,可列舉由此等纖維所構成之不織布、梭織物、針織物、紙等。(2) Substrate The
多孔性的基材11的基材孔部係與針狀部12的孔部13連通而形成連通孔。基材孔部的形狀係依據基材的材質而決定。多孔性的基材11較佳為由基材孔部所導致之空隙率為1~70%,更佳為5~50%,特佳為10~30%。藉由空隙率在此範圍,而可充分地吸收針狀部12所吸收到之體液。如後述,多孔性的基材11較佳為含有第二水不溶性材料,在包含第二水不溶性材料之基材11中亦維持著基材孔部。又,在此基材11直接接著有針狀部12。例如,在藉由接著劑層等而接著基材11與針狀部12之情形中,在基材11與針狀部12之間產生空隙,有液體漏出、或因接著劑層而基材11與針狀部12之間的液體的通過受到妨礙之虞,但藉由將基材11與針狀部12直接接著,而容易連接兩者的通道。The substrate pore portion of the
又,作為於厚度方向具有液體穿透性之基材,不僅可採用基材11本身係由具有液體穿透性之材料所構成者,還可採用以下述方式所構成者:由具有液體不穿透性之材料所構成,且透過形成於基材11之貫通孔而使液體於基材11的厚度方向通過。藉由基材11具有液體不穿透性,而可抑制基材11吸收液體,因此液體在基材11中可僅通過貫通孔內。因此,由針狀部12所得之體液或輸送往針狀部12之藥液不會在基材11內滲出,可使全部的量透過貫通孔而流通。藉此,在將該微針構造體10使用作為檢查貼片之情形中,因體液可快速通過基材11,故可使迅速的分析成為可能,又,即使為將該微針構造體10利用作為藥劑投予貼片之情形,藥液亦不會滲出,可將藥液全部的量迅速地供給往皮膚。Also, as the base material having liquid-permeability in the thickness direction, not only the
作為此種具有液體不穿透性之材料,可列舉樹脂薄膜、金屬箔、玻璃薄膜等,較佳為使用樹脂薄膜。貫通孔的形狀未被特別限定,但由使毛細管現象產生且確保充分的流通量之觀點而言,較佳為設有多個直徑細小的貫通孔之結構。作為貫通孔的直徑,例如直徑為2mm以下,較佳為0.05~1mm,更佳為0.1~0.8mm。貫通孔可藉由衝孔加工、雷射穿孔等而設置。作為使用於樹脂薄膜之樹脂,可列舉聚對苯二甲酸丁二酯(polybutylene terephthalate)、聚對苯二甲酸乙二酯、聚乙烯、聚丙烯、乙烯-乙酸乙烯酯共聚物、氯乙烯、丙烯酸樹脂、聚氨酯、聚乳酸等。基材11可為將設有貫通孔之樹脂薄膜與多孔性的基材進行層積而成之層積基材。Examples of such liquid-impermeable materials include resin films, metal foils, and glass films, and resin films are preferably used. The shape of the through-hole is not particularly limited, but from the viewpoint of generating capillarity and securing a sufficient flow rate, a structure having a plurality of through-holes with a small diameter is preferable. The diameter of the through hole is, for example, 2 mm or less, preferably 0.05 to 1 mm, more preferably 0.1 to 0.8 mm. The through holes can be formed by punching, laser drilling, or the like. Examples of the resin used for the resin film include polybutylene terephthalate, polyethylene terephthalate, polyethylene, polypropylene, ethylene-vinyl acetate copolymer, vinyl chloride, acrylic acid Resin, polyurethane, polylactic acid, etc. The
在基材11的形成有針狀部12之面設有接著劑層之情形中,可在常溫進行後述之接著步驟、或可提高基材11與針狀部12的接著性。此情形,因存在接著劑層,故在基材11與針狀部12之間產生空隙,而有液體漏出、或因接著劑層而基材11與針狀部12之間的液體的通過受到阻礙之虞。因此,較佳為在基材11中,以包含液體應通過的區域之方式設置接著劑層,且在中央部設置接著劑層的非形成區域。In the case where an adhesive layer is provided on the surface of the
如此,本實施形態的微針構造體10係以所期望的形狀形成針狀部12,且係以由針狀部12的孔部13與基材11的基材孔部所構成之通道的液體穿透性良好之方式針狀部12與基材11的接合良好者。In this way, the
[檢查貼片] 較佳為,微針構造體10被利用於檢查貼片20,所述檢查貼片20透過針狀部12而從皮膚內吸收體液並使用所得之體液進行檢查。如圖2所示,檢查貼片20具有微針構造體10,其在基材11的與設有針狀部12之面相反的面(以下,有時稱為「背面」)側具有分析片21與膠膜22。此外,微針構造體10亦能利用作為從基材11透過針狀部12而將藥劑從皮膚投予至體內之藥劑投予貼片。在此情形中,能以下述方式構成藥劑投予貼片:可在微針構造體10的基材11的背面側設置含有生理活性物質的片,並透過基材11及針狀部12而將來自含有生理活性物質的片之生理活性物質投予至皮膚內。[Inspection patch] Preferably, the
分析片21係用於分析並檢查從皮下所取得之血液、間質液等體液者,並設置於基材11的背面側。若將針狀部12刺於對象的皮膚,則體液從針狀部12的孔部13流入並被基材11吸收且通過基材孔部而到達分析片21。分析片21可因應所期望的檢查內容而適當選擇,可使用藉由在紙等基材中包含作為分析手段的成分而形成者。作為此種分析片21,可列舉例如因應體液中的葡萄糖濃度而變色之葡萄糖測量紙。在使用葡萄糖測量紙作為分析片21之情形中,可被利用作為血糖値測量用的檢查貼片20,所述血糖値測量用的檢查貼片20的分析片21會吸收藉由微針構造體10所採取到之間質液並進行變色,而利用此變色的程度經時地測量血糖値。The
膠膜22係由具有活體安全性之材質所構成,若考慮對於所貼附之皮膚的追隨性,則較佳為由具有柔軟性、伸縮性、甚至收縮性之材料所構成,但並不受限於此材料。作為膠膜22的較佳材料,可列舉伸縮性梭織物,並可使用以往習知者。
[微針構造體的製造方法] (填充步驟) 圖3中表示本發明的一實施形態之微針構造體10的製造方法。在本實施形態中,如圖3(a)所示,將液狀組成物3填充至形成有多個凹部1之模具(mold)2(填充步驟)。凹部1被所填充之液狀組成物3填滿。[Method for Manufacturing Microneedle Structure] (Filling Step) FIG. 3 shows a method for manufacturing a
模具2的材質未被特別限定,但例如較佳為由容易製作正確的模具且已固化之液狀組成物3容易剝離之聚矽氧化合物等所形成,在本實施形態中,係由聚二甲基矽氧烷所構成。該凹部1係用於形成圖1所示之針狀部12者,且被構成為可形成所期望的形狀的針狀部12。在模具2中,在指定的位置,多個此凹部1係互相隔開間隔並設置多行。The material of the
液狀組成物3包含:前述的第一水不溶性材料(圖3(a)中示意性地以淺灰色的圓所示)、可溶於水之第一水溶性材料(圖3(a)中示意性地以深灰色的圓所示)以及溶劑。此外,在圖中,為了說明,示意性地將各材料記載成粒子狀,並表示為在溶劑中分散存在之狀態。液狀組成物3只要在溶劑中溶解有第一水不溶性材料及第一水溶性材料(針狀部形成用的組成物)的至少一者即可,由容易在針狀部12形成多孔結構之觀點而言,較佳為至少溶解有第一水不溶性材料。液狀組成物3較佳為黏度為0.1~1000mPa・s,更佳為0.5~100mPa・s,特佳為1.0~10mPa・s。藉由為此範圍,可作業性佳地將液狀組成物3注入模具2,填充步驟中之組成物對於凹部1的填充性亦佳,因此可形成所期望的針狀部12。The
作為第一水溶性材料,較佳為熔點高於常溫之水溶性材料。水溶性材料可為有機物,亦可為無機物,可列舉氯化鈉、氯化鉀、芒硝、碳酸鈉、硝酸鉀、明礬、砂糖、水溶性樹脂等。作為水溶性樹脂,較佳為水溶性的熱塑性樹脂,且較佳為熔點高於常溫者。作為水溶性的熱塑性樹脂,除了後述之生物分解性樹脂以外,還可列舉羥基丙基纖維素、聚乙烯基吡咯啶酮等。進一步考慮對於人體的影響,水溶性的熱塑性樹脂更佳為生物分解性樹脂。作為此種生物分解性樹脂,可列舉選自由聚乙二醇、聚丙二醇等聚烯烴二醇、聚乙烯醇、膠原蛋白及其等之混合物所組成之群組的至少1種,特佳為聚乙二醇。聚乙二醇的分子量例如較佳為200~4,000,000,更佳為600~500,000,特佳為1,000~100,000。As the first water-soluble material, it is preferably a water-soluble material with a melting point higher than normal temperature. The water-soluble material may be organic or inorganic, and examples thereof include sodium chloride, potassium chloride, Glauber's salt, sodium carbonate, potassium nitrate, alum, sugar, and water-soluble resins. The water-soluble resin is preferably a water-soluble thermoplastic resin, and preferably has a melting point higher than normal temperature. Examples of the water-soluble thermoplastic resin include hydroxypropyl cellulose, polyvinylpyrrolidone, and the like in addition to the biodegradable resins described below. In further consideration of the impact on the human body, the water-soluble thermoplastic resin is more preferably a biodegradable resin. Such biodegradable resins include at least one selected from the group consisting of polyolefin glycols such as polyethylene glycol and polypropylene glycol, polyvinyl alcohol, collagen, and mixtures thereof, particularly preferably poly ethylene glycol. The molecular weight of polyethylene glycol is, for example, preferably from 200 to 4,000,000, more preferably from 600 to 500,000, particularly preferably from 1,000 to 100,000.
第一水不溶性材料與第一水溶性材料較佳為以質量比計係以9:1~1:9進行混合,更佳為以8:2~2:8進行混合,特佳為以7:3~3:7進行混合。藉由以此比例構成液狀組成物3,而形成所期望的空隙率的針狀部12,變得容易兼顧針狀部12的液體穿透性與強度。The first water-insoluble material and the first water-soluble material are preferably mixed at a mass ratio of 9:1 to 1:9, more preferably 8:2 to 2:8, particularly preferably 7:1 3~3:7 for mixing. By constituting the
在本實施形態中,為了包含各材料且呈液狀,液狀組成物3包含溶劑。溶劑可為水,亦可為有機溶劑,但在使第一水不溶性材料溶解之情形中,液狀組成物3較佳為包含有機溶劑。有機溶劑只要為可使前述的第一水不溶性材料及第一水溶性材料溶解或分散之有機溶劑即可。例如可使用己烷、庚烷、環己烷等脂肪族烴、甲苯、二甲苯等芳香族烴、二氯甲烷(methylene chloride)、二氯乙烷(ethylene chloride)等鹵化烴、甲醇、乙醇、丙醇、丁醇、1-甲氧基-2-丙醇等醇、丙酮、甲基乙基酮、2-戊酮、異佛酮、環己酮等酮、乙酸乙酯、乙酸丁酯等酯、乙基賽路蘇等賽路蘇(cellosolve)系溶劑等。In this embodiment, the
液狀組成物3的全部成分中之第一水不溶性材料及第二水不溶性材料的含量的合計,以質量基準計較佳為40%以下,更佳為35%以下,特佳為30%以下。藉由相對於液狀組成物3的全部量以此範圍含有組成物,而能以容易製造微針構造體10的針狀部12之所期望的黏度形成液狀組成物3,其結果,能以所期望的形狀形成針狀部12。The total content of the first water-insoluble material and the second water-insoluble material in all components of the
此外,液狀組成物3中,作為非揮發性固體成分,可不僅包含前述之第一水不溶性材料亦即樹脂及第一水溶性材料,更進一步包含其他材料。In addition, the
本實施形態中雖使用使各材料溶解或分散於溶劑而成之液狀組成物3,但液狀組成物3亦可為僅由不包含溶劑之組成物所構成者,又,液狀組成物3亦可進一步具備分散劑。例如,為了進一步提高針狀部的強度,亦可包含矽石填料(silica filler)等樹脂以外的水不溶性材料。在將不包含溶劑之組成物填充於模具之情形中,較佳為將組成物進行加熱使其流動化。In this embodiment, although the
(振動步驟) 接著,作為振動步驟,較佳為將模具2載置於超音波清洗裝置,並使模具2進行超音波振動。作為賦予振動之手段,只要為可對模具2賦予細微的振動者,則不受限於超音波清洗裝置。藉由進行此種振動步驟,如圖3(b)所示,促進液狀組成物3對於凹部1的填充,並進一步將凹部1內的第一水不溶性材料與第一水溶性材料填充至凹部1內的各個角落。藉由此填充,不會有由氣泡所導致之缺點等,可形成因應凹部1的形狀之轉移性高的針狀部12,並且,針狀部12的強度提升。(Vibration Step) Next, as a vibration step, it is preferable to place the
在進行作為振動步驟的超音波處理之際,可同時進行加溫,在該情形中,以可促進蒸發/乾燥之溫度以上(例如45℃以上)進行加溫,特佳為以第一水不溶性材料及第一水溶性材料的至少任一者的熔點以上(例如60℃以上)進行加溫。藉由以此溫度進行加溫,而抑制液狀組成物3的表面固化,促進有機溶劑的蒸發/乾燥,並促進液狀組成物3內的第一水不溶性材料及第一水溶性材料對於凹部1的填充。尤其,藉由以60℃以上進行加溫,而更促進有機溶劑的蒸發/乾燥,並進一步促進第一水不溶性材料及第一水溶性材料對於凹部1的填充。When performing ultrasonic treatment as a vibration step, heating may be carried out at the same time. In this case, heating is carried out at a temperature above a temperature that can promote evaporation/drying (for example, above 45° C.), and it is particularly preferred to use the first water-insoluble Heating is performed at least one of the melting point of the material and the first water-soluble material (for example, 60° C. or higher). By heating at this temperature, the solidification of the surface of the
振動步驟中之頻率,較佳選擇填充的促進效果高之低頻率的範圍,較佳為10~200kHz,更佳為20~150kHz,特佳為30~80kHz。又,振動步驟中,進行超音波處理之時間較佳為0.5~10分鐘,更佳為2~7分鐘。藉由在此範圍使模具2振動,而更促進液狀組成物3內的第一水不溶性材料及第一水溶性材料對於凹部1的填充。The frequency in the vibrating step is preferably selected from a low frequency range with a high filling acceleration effect, preferably 10-200kHz, more preferably 20-150kHz, particularly preferably 30-80kHz. Also, in the vibration step, the time for ultrasonic treatment is preferably 0.5 to 10 minutes, more preferably 2 to 7 minutes. By vibrating the
(脫氣步驟) 振動步驟的下一步較佳為進行脫氣步驟。藉此,可將凹部1內所含之空氣進行脫氣,可進一步促進第一水不溶性材料及第一水溶性材料對於凹部1的填充,且同時可促進有機溶劑的蒸發/乾燥。脫氣步驟例如如後述之實施例,在使用乙酸乙酯作為溶劑之情形中,較佳為以0.01~0.05MPa、20~25℃進行。藉由在此壓力範圍進行脫氣,而抑制液狀組成物3在表面進行固化,使有機溶劑容易蒸發/乾燥,而能進一步促進第一水不溶性材料及第一水溶性材料對於凹部1的填充。(Degassing step) It is preferable to perform a degassing step next to the shaking step. Thereby, the air contained in the
(加熱步驟) 之後,較佳為進行以80~120℃進行加熱之加熱步驟。藉此,如圖3(c)所示,在進一步促進溶劑的蒸發/乾燥且同時已加熱至第一水不溶性材料及第一水溶性材料的任一者的熔點以上之情形中,該材料成為已熔融之狀態,而促進第一水不溶性材料及第一水溶性材料對於凹部1的填充。此外,在本實施形態中,雖在脫氣步驟後進行加熱步驟,但亦可先進行加熱步驟。(Heating Step) After that, it is preferable to perform a heating step of heating at 80 to 120°C. Thereby, as shown in FIG. 3( c ), in the case where the evaporation/drying of the solvent is further promoted while having been heated above the melting point of any one of the first water-insoluble material and the first water-soluble material, the material becomes The melted state promotes the filling of the
之後,溶劑蒸發/乾燥,液狀組成物3所含有之第一水不溶性材料與第一水溶性材料被充分地填充至凹部1內,在凹部1內已形成突起部5之狀態下,如圖3(d)所示,將片4載置於模具2。如此,藉由充分地進行第一水不溶性材料與第一水溶性材料對於凹部1的填充,而在本實施形態中能以所期望的形狀具有針狀部12,針狀部12與基材11的接著性亦佳。如此,在本實施形態中,藉由填充步驟、接續於此的振動步驟、脫氣步驟及加熱步驟,而進行形成突起部5之形成步驟。又,亦可省略振動步驟及/或脫氣步驟。或者,藉由以室溫使溶劑乾燥,可不進行加熱步驟而形成突起部5。Afterwards, the solvent is evaporated/dried, and the first water-insoluble material and the first water-soluble material contained in the
(片) 片4係在前述之多孔性的基材11中含有可溶於水之第二水溶性材料與不溶於水之第二水不溶性材料而成者。因在此之前的步驟中加熱模具2,故凹部1內的第一水不溶性材料與第一水溶性材料為已熔融之狀態,若載置片4,則由凹部1內的已熔融之第一水不溶性材料與第一水溶性材料所構成之突起部5會對片4進行直接接著。在此情形中,因片4為包含第二水不溶性材料及第二水溶性材料者,故可抑制基材11吸收凹部1內的已熔融之組成物的狀況。其結果,即使微針構造體10具備多孔性的基材11並且係使用液狀的材料所形成,亦因突起部5的特別是根部未形成過多的空隙,故抑制針狀部12會崩塌的狀況。因此,可形成具有適於與基材11的接著之形狀之針狀部12,可製造針狀部12與基材11的接著良好的微針構造體10。再者,因片4為不僅包含第二水溶性材料更包含第二水不溶性材料者,故藉由凹部1內的已熔融之第一水不溶性材料與片4包含之第二水不溶性材料進行熱封,而片4與突起部5的接著性進一步提升。(Sheet) The
作為第二水溶性材料,可使用針對第一水溶性材料所列舉者,但如後述,為了變得容易使多孔性的基材11含浸第二水溶性材料,較佳為水溶性的樹脂,較佳為水溶性的熱塑性樹脂,再佳為水溶性的生物分解性樹脂。較佳為第二水溶性材料係與第一水溶性材料相同。藉由第二水溶性材料與第一水溶性材料相同,在之後的去除步驟中,變得容易去除第二水溶性材料與第一水溶性材料,可形成所期望的針狀部12的孔部13。As the second water-soluble material, those listed for the first water-soluble material can be used, but as described later, in order to easily impregnate the
第二水不溶性材料可使用針對第一水不溶性材料所列舉者,但較佳為第二水不溶性材料係與第一水不溶性材料相同。藉由第二水不溶性材料與第一水不溶性材料相同,第二水不溶性材料與第一水不溶性材料變得更容易進行熱封,突起部5與片4的接著性提高。The second water-insoluble material can use those listed for the first water-insoluble material, but preferably the second water-insoluble material is the same as the first water-insoluble material. Since the second water-insoluble material is the same as the first water-insoluble material, the heat-sealing between the second water-insoluble material and the first water-insoluble material becomes easier, and the adhesion between the
又,作為第二水不溶性材料,如後述,為了變得容易使多孔性的基材11含浸第二水溶性材料,較佳為水不溶性樹脂。水不溶性樹脂較佳為其熔點為高於常溫且250℃以下之水不溶性樹脂,更佳為其熔點為高於40℃且200℃以下之水不溶性樹脂,特佳為其熔點為高於45℃且150℃以下之水不溶性樹脂。使用作為第二水不溶性材料之樹脂,亦較佳為生物分解性。Also, as the second water-insoluble material, as described later, a water-insoluble resin is preferable in order to facilitate impregnation of the
對於片4,可任意含有第二水溶性材料與第二水不溶性材料,但片4只要以不會從基材11的與突起部5(針狀部12)接著之面側吸收來自凹部1的第一水不溶性材料與第一水溶性材料之方式至少含有第二水溶性材料即可。亦即,片4只要以下述方式構成即可:至少含有第二水溶性材料,並藉由此第二水溶性材料阻塞多孔性的基材11的基材孔部的至少一部分,而可抑制第一水不溶性材料與第一水溶性材料的吸收。例如,包含第二水溶性材料與第二水不溶性材料之層,可被層積於多孔性的基材11的接著突起部5之側的面。較佳為,使多孔性的基材11含浸第二水溶性材料與第二水不溶性材料。作為使多孔性的基材11含浸第二水溶性材料與第二水不溶性材料之方法,例如,只要將多孔性的基材11浸漬於具有第二水溶性材料與第二水不溶性材料之溶液內即可。又,藉由噴墨方式等,可將具有第二水溶性材料與第二不溶性材料之溶液塗布於多孔性的基材11。使浸入多孔性的基材11之具有第二水溶性材料與第二水不溶性材料之溶液乾燥,使第二水溶性材料與第二不溶性材料殘留於基材11的基材孔部中,此為簡便的含浸手段而較佳。該溶液可不僅具有第二水溶性材料與第二水不溶性材料,還進一步具有溶劑。溶液的全部成分中,第二水溶性材料及第二水不溶性材料的合計的含有濃度,以質量基準計,較佳為1~35%,更佳為3~30%,特佳為5~25%。溶液較佳為以質量比計係以9:1~1:9含有第二水溶性材料與第二水不溶性材料。藉由為此範圍,在後述之去除步驟中,變得容易獲得復原基材11的基材孔部之效果,並且,容易提高基材11與針狀部12的接著性。The
使多孔性的基材11浸漬於包含第二水溶性材料與第二水不溶性材料之溶液之情形,例如,使基材11在10~60℃浸漬於溶液中1~60分鐘後,使溶劑蒸發,藉由乾燥而可使基材11含浸第二水溶性材料與第二水不溶性材料。尤其,在由纖維狀物質構成基材11之情形,藉由浸漬於溶液中,而能簡易地且充分地吸收第二水溶性材料與第二水不溶性材料並使基材11含浸。When the
在本實施形態中,片4係以含有第二水不溶性材料之方式構成,但不受限於此。片4亦可不含有第二水不溶性材料,因加熱模具2故凹部1內的第一水不溶性材料與第一水溶性材料為已熔融之狀態,若載置片4,則由凹部1內的已熔融之第一不溶性材料與第一水溶性材料所構成之突起部5會接著於所載置之片4的表面。片4不含有第二水不溶性材料之情形,例如,藉由在片4的載置模具2之側的面設置任意的接著手段,例如設置使用習知的接著劑之接著部,而可提高片4與突起部5的接著性。In this embodiment, the
(加壓步驟) 接著,如圖3(e)所示,進行對片4施加壓力之加壓步驟。加壓方法未被特別限定,可使用習知的方法。在加壓步驟中,亦可同時進行以60~120℃進行加熱之加熱步驟。藉由亦同時進行加熱步驟,而能進一步提高接著性。其後,藉由保持在-10~3℃的低溫狀態,而凹部1內的突起部5會固化,且同時突起部5與片4的接著結束。如此,在本實施形態中,藉由加熱步驟及接續於此的加壓步驟與突起部5的固化,而進行將突起部5與片4進行接著之接著步驟。又,亦可不進行加壓步驟,而僅以加熱步驟使突起部5與片4接著。或者,亦可藉由上述之接著手段,不伴隨加熱步驟及加壓步驟之任一者,而將突起部5與片4進行接著。如本實施形態般,在液狀組成物3含有溶劑之情形中,藉由在填充步驟後使溶劑蒸發,而開始固定針狀部形成用的組成物的形狀(形成步驟)。因此,無法在形成步驟之前先實施針狀部形成用的組成物與基材11的接著步驟,接著步驟必須在形成步驟後進行,但在本發明中,因片4包含水溶性材料,故能抑制由基材11所致之針狀部形成用的組成物的吸收,並能以所期望的形狀獲得針狀部。(Pressing Step) Next, as shown in FIG. 3(e), a pressing step of applying pressure to the
(去除步驟) 接著步驟結束後,如圖3(f)所示,進行去除步驟,其使接著經固化之突起部5與片4而成者從模具2分開,並去除突起部5及片4的水溶性材料。(Removal step) After the next step is completed, as shown in FIG. 3(f), a removal step is performed, which separates the protruding
此去除步驟中之清洗液為包含水者,去除步驟例如係藉由將接著突起部5與片4而成者靜置於清洗液中而進行。藉由靜置於包含水之清洗液中,突起部5及片4所含有之第一水溶性材料及第二水溶性材料之中與外部連通的部分會溶解,並流入水中而被去除。此外,清洗液亦可為水與醇等的混合溶劑。藉由此去除,如圖3(g)所示般在突起部5形成孔部13,並形成作為針狀部12。藉此,獲得微針構造體10。去除步驟中,藉由去除第二水溶性材料,被第二水溶性材料阻塞之基材11的基材孔部會至少局部地復原,因此片4變得會表現良好的液體穿透性。又,片4包含第二水溶性材料及第二水不溶性材料之情形,基材11成為包含第二水不溶性材料且基材孔部已復原者。此情形,藉由使第一水溶性材料與第二水溶性材料接觸之部分溶解,而使第二水不溶性材料殘留於基材11中,且針狀部12之延伸至基材11側為止的孔部13會進一步與基材11的基材孔部連結。已與基材孔部連結之孔部13構成液體的通道。藉此,在微針構造體10中,液體變得容易通過針狀部12與基材11之間的界面。The cleaning solution in this removal step contains water, and the removal step is performed by, for example, placing the protruding
(突起部形成手段的變形例) 在本實施形態中,雖在凹部1內填充液狀組成物3而形成針狀部12,但不受限於此。例如,形成步驟亦可為由以下手法所致者:以高黏度製備液狀組成物3,並利用分配器等而將此高黏度的液狀組成物3滴下至多孔質的基材11上,藉此形成針狀部12。即使為此情形,藉由在基材11中至少包含第一水溶性材料,亦能抑制液狀組成物3被基材11吸收而針狀部12無法獲得所期望的形狀之情況。(Modification of Protrusion Forming Means) In the present embodiment, the
在本實施形態中,雖在凹部1內填充含有第一水不溶性材料、可溶於水的第一水溶性材料及溶劑之液狀組成物3而形成針狀部12,但亦可藉由使含有第一水不溶性材料與可溶於水的第一水溶性材料且不含有溶劑之組成物一邊熔融一邊填充至凹部1內,而形成突起部5。具體而言,首先將此種組成物成型為適當的形狀(例如,圓盤狀)而製作固體組成物。然後,在片4預先設置接著劑層,將片4的接著劑層與固體組成物的一側的面進行貼合。藉此,在常溫實施將形成針狀部12前的組成物與基材11進行接著之接著步驟。其後,使附基材的固體組成物之與貼合有基材之一側的面相反的面面向凹部1,將固體組成物一邊進行加熱使其熔融一邊填充至凹部1內,其後,藉由冷卻而形成突起部5。在微針構造體10中,若所得之針狀部12具有多孔結構,則針狀部12對於基材11之接著面積變小,對此等之間的接著性而言變得不利,但在如此基材11與固體組成物已接著之狀態下,藉由經過形成步驟中之加熱,可使針狀部12與基材11之間的接著性提升。In the present embodiment, although the
[檢查貼片的製造方法] 藉由將分析片21配置於所得之微針構造體10的基材11的背面側的指定位置(設置步驟),並以覆蓋分析片21之方式層積膠膜22,而能製造檢查貼片。層積方法可使用以往習知的方法,例如,藉由在已將分析片21載置於基材11的背面側之後,層積將一般所使用之橡膠系黏著劑、丙烯酸系黏著劑、聚矽氧系黏著劑等黏著劑層形成於膠膜基材上而成之黏著膠膜22,而可製造檢查貼片。藥劑投予貼片亦能藉由同樣的方法而製造。[Manufacturing method of inspection patch] By disposing the
[微針構造體及其製造方法的變形例] 在上述的微針構造體及其製造方法的實施形態中,雖在基材11上直接設置有多個針狀部12,但針狀部12亦可具有基部,並將一個個針狀部12透過基部而設置於基材11上,其中,所述基部成為一個個針狀部12的底座,且與一個個針狀部12同樣地具有孔部。在此情形中,只要基部係由與針對針狀部12所說明之材料同樣者所構成,或係藉由同樣的步驟所形成者,則針狀部12與基材11亦可透過基部獲得良好的接著性。上述的填充步驟中,為了形成基部,只要將比起相當於凹部1之體積為過剩的液狀組成物3填充至模具2,且使其從凹部1溢出即可。在此情形中,藉由在模具2的凹部1形成面設置壁部,相當於設置儲液部,並在此儲液部蓄積從凹部1溢出之液狀組成物,而可形成基部。[Modification of microneedle structure and its manufacturing method] In the above-mentioned embodiment of the microneedle structure and its manufacturing method, although a plurality of needle-
在本實施形態中,雖使用在多孔性的基材11含有可溶於水的第二水溶性材料與不溶於水的第二水不溶性材料而成之片4,但亦可取代此情形而使設有貫通孔之樹脂薄膜與突起部5接著。此情形,去除步驟中,藉由使第一水溶性材料溶解,而針狀部12的延伸至基材11側為止之孔部13會進一步與基材11的貫通孔連結。已與貫通孔連結之孔部13構成液體的通道。藉此,在微針構造體10中,液體變得容易從針狀部12通過基材11的貫通孔而到達基材11之與設有針狀部12的面相反側的面。In the present embodiment, although the
以下,藉由實施例而更詳細地說明本發明。 [實施例] 摻合100重量份之作為第一水溶性材料的聚乙二醇(分子量4000,熔點40℃)、100重量份之作為第一水不溶性材料的聚己內酯(分子量10,000,熔點60℃)、800重量份之作為溶劑(有機溶劑)的乙酸乙酯,製備固體成分濃度20%的液狀組成物。 Hereinafter, the present invention will be described in more detail by means of examples. [Example] Blend 100 parts by weight of polyethylene glycol (molecular weight 4000, melting point 40°C) as the first water-soluble material, and 100 parts by weight of polycaprolactone (molecular weight 10,000, melting point 40°C) as the first water-insoluble material. 60° C.), 800 parts by weight of ethyl acetate as a solvent (organic solvent), and a liquid composition having a solid content concentration of 20%.
將0.7ml的該液狀組成物注入具有下述形狀等的凹部且由聚二甲基矽氧烷所構成之模具。模具的填充液狀組成物之區域的尺寸係四邊15mm的正方形,且在凹部形成面的上方設有儲液部。經液狀組成物填充至比凹部形成面更上方為止,且針狀部具備基部。 ・凹部形狀:剖面正方形的四角重錘形狀 ・凹部的最大剖面的一邊的長度:500μm ・凹部的高度:900μm ・凹部的間隔:1000μm ・凹部的數量:一縱行13個,13行共計169個 ・凹部的配置:正方形格子狀 0.7 ml of the liquid composition was poured into a mold made of polydimethylsiloxane having a concave portion having the following shape and the like. The size of the region of the mold filled with the liquid composition was a square with four sides of 15 mm, and a liquid storage part was provided above the surface where the concave part was formed. The liquid composition is filled up to the upper side of the concave portion formation surface, and the needle-shaped portion has a base. ・Shape of recessed part: Square weight shape with square cross section ・Length of one side of the largest cross section of the concave part: 500μm ・Height of concave part: 900μm ・Interval between recesses: 1000μm ・Number of recesses: 13 per wale, 169 in total in 13 rows ・Arrangement of concave parts: Square lattice shape
接著,將模具載置於超音波清洗裝置(超音波清洗機AU-10C/Aiwa Medical Industry Co., Ltd.製)並在溫度23℃的環境下進行1分鐘超音波處理。Next, the mold was placed on an ultrasonic cleaning device (ultrasonic cleaning machine AU-10C/manufactured by Aiwa Medical Industry Co., Ltd.), and ultrasonic treatment was performed for 1 minute in an environment at a temperature of 23°C.
接著,作為脫氣步驟,在溫度23℃、壓力0.05MPa的減壓環境下進行30分鐘真空乾燥。之後,在110℃、無調整濕度的環境下加熱30分鐘。Next, as a degassing step, vacuum drying was performed for 30 minutes in a reduced-pressure atmosphere at a temperature of 23° C. and a pressure of 0.05 MPa. Thereafter, heating was performed for 30 minutes at 110° C. in an environment without adjusting the humidity.
另一方面,摻合100重量份之作為第二水溶性材料的聚乙二醇(與第一水溶性材料相同者)、100重量份之作為第二水不溶性材料的聚己內酯(與第一水溶性材料相同者)、1800重量份之作為溶劑(有機溶劑)的乙酸乙酯,製備固體成分濃度10%的溶液。又,使作為多孔性基材的濾紙(WHATMAN FILTER PAPER GRADE4/GE Healthcare Life Siences公司製)浸漬於上述的溶液後再取出,以23℃的條件使其乾燥60分鐘,藉此製作片。On the other hand, 100 parts by weight of polyethylene glycol (the same as the first water-soluble material) as the second water-soluble material, and 100 parts by weight of polycaprolactone (the same as the first water-soluble material) as the second water-insoluble material were blended. One water-soluble material is the same), 1800 parts by weight of ethyl acetate as a solvent (organic solvent), and a solution with a solid content concentration of 10% is prepared. In addition, filter paper (WHATMAN FILTER PAPER GRADE4/GE Healthcare Life Sciences Co., Ltd.) as a porous substrate was immersed in the above solution, taken out, and dried at 23° C. for 60 minutes to prepare a sheet.
將片載置於基部的露出面,所述基部的露出面設在形成於加熱後的模具中的凹部之突起部的上方,並將重錘(500g)載於所載置之片上,藉此進行加壓步驟。其後,在3℃的低溫狀態下保持10分鐘後,將接著突起部、基部及片而成者從模具剝離,浸漬於23℃的純化水中24小時,溶解並去除突起部、基部及片中的第一水溶性材料及第二水溶性材料。The sheet was placed on the exposed surface of the base provided above the protrusion of the recess formed in the heated mold, and a weight (500 g) was placed on the placed sheet, whereby A pressurization step is performed. Thereafter, after keeping it at a low temperature of 3°C for 10 minutes, peel off the protrusion, base, and sheet from the mold, and immerse in purified water at 23°C for 24 hours to dissolve and remove the protrusion, base, and sheet. The first water-soluble material and the second water-soluble material.
其後,溶解並去除第一水溶性材料及第二水溶性材料,將接著突起部、基部及片而成者在23℃、相對濕度50%的環境下靜置24小時,使水分蒸發並進行乾燥,製作微針構造體。Thereafter, the first water-soluble material and the second water-soluble material are dissolved and removed, and the protruding portion, the base portion, and the sheet are bonded and left standing for 24 hours at 23° C. and a relative humidity of 50% to evaporate the water and carry out After drying, a microneedle structure is produced.
作為比較例,除了不進行使多孔性的基材浸漬於溶液之步驟以外,與實施例同樣地進行而製作微針構造體。As a comparative example, a microneedle structure was produced in the same manner as in the examples except that the step of immersing the porous base material in the solution was not performed.
針對由實施例及比較例所得之微針構造體,利用鑷子將針狀部的根部從基材剝離,以光學顯微鏡(倍率:50倍及100倍)觀察針狀部內部。在實施例的微針構造體之情形中,雖將樹脂幾乎無間隙地填充至針狀部的根部的內部,但在比較例的微針構造體中,有間隙、空洞等,填充並不充分。For the microneedle structures obtained in Examples and Comparative Examples, the root of the needle-shaped part was peeled off from the base material with tweezers, and the interior of the needle-shaped part was observed with an optical microscope (magnification: 50 times and 100 times). In the case of the microneedle structure of the example, the resin was filled almost without gaps in the base of the needle-shaped part, but in the microneedle structure of the comparative example, there were gaps, cavities, etc., and the filling was not sufficient. .
接著,在實施例及比較例中,藉由冷卻組成物而形成突起部,在從模具剝離後且浸漬於純化水前,以光學顯微鏡(倍率:50倍及100倍)觀察突起部,計算針狀部殘留於基材上之數量。計算此殘留數相對於在設計上的針狀部的全部數量之比例,作為轉移率。在由實施例所得之微針構造體中,若轉移率為50%以上則轉移性佳,而由比較例所得之微針構造體的轉移率小於50%且轉移性低。 [產業利用性] Next, in Examples and Comparative Examples, the protrusions were formed by cooling the composition, and the protrusions were observed with an optical microscope (magnification: 50 times and 100 times) after peeling off from the mold and before immersing in purified water, and the needles were calculated. The amount of shape parts remaining on the substrate. The ratio of this number of residues to the total number of designed needles was calculated as the transfer rate. In the microneedle structure obtained in the example, if the transfer rate is more than 50%, the transferability is good, while the transfer rate of the microneedle structure obtained in the comparative example is less than 50%, and the transferability is low. [Industrial Utilization]
本發明的微針構造體,例如,可藉由將分析片配置於背面側並利用膠膜進行層積而被使用作為檢查貼片。The microneedle structure of the present invention can be used as an inspection patch, for example, by arranging an analysis sheet on the back side and laminating it with an adhesive film.
1:凹部 2:模具 3:液狀組成物 4:片 5:突起部 10:微針構造體 11:基材 12:針狀部 13:孔部 20:檢查貼片 21:分析片 22:膠膜 1: Concave 2: Mold 3: liquid composition 4: piece 5: Protrusion 10: Microneedle structure 11: Substrate 12: Acicular part 13: Hole 20: Check the patch 21: Analysis sheet 22: film
圖1為本發明的微針構造體的示意性的局部剖面圖。 圖2為使用本發明的微針構造體之檢查貼片的剖面圖。 圖3為表示微針構造體的製造方法的流程之說明圖。 FIG. 1 is a schematic partial cross-sectional view of the microneedle structure of the present invention. Fig. 2 is a cross-sectional view of an inspection patch using the microneedle structure of the present invention. FIG. 3 is an explanatory diagram showing the flow of a method of manufacturing a microneedle structure.
10:微針構造體 10: Microneedle structure
11:基材 11: Substrate
12:針狀部 12: Acicular part
13:孔部 13: Hole
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021062451 | 2021-03-31 | ||
JP2021-062451 | 2021-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202304546A true TW202304546A (en) | 2023-02-01 |
Family
ID=83456633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111112637A TW202304546A (en) | 2021-03-31 | 2022-03-31 | Microneedle structure production method and microneedle structure |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPWO2022211058A1 (en) |
KR (1) | KR20230163360A (en) |
CN (1) | CN116867537A (en) |
TW (1) | TW202304546A (en) |
WO (1) | WO2022211058A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007127976A2 (en) * | 2006-05-01 | 2007-11-08 | Georgia Tech Research Corporation | Particle based molding |
JP2014094171A (en) | 2012-11-09 | 2014-05-22 | Canon Inc | Microneedle and microneedle array |
JP2017000724A (en) * | 2015-06-05 | 2017-01-05 | 国立大学法人東北大学 | Micro needle and micro array and method for producing the same |
KR101621945B1 (en) * | 2015-07-02 | 2016-05-17 | 주식회사 엘지생활건강 | Nano-porous microneedle having two layers and its manufacturing method |
JP7229483B2 (en) * | 2017-08-30 | 2023-02-28 | 国立大学法人東北大学 | Skin patch devices and kits comprising skin patch devices for the detection, diagnosis or treatment of skin diseases or conditions. |
CN111836582A (en) * | 2018-03-16 | 2020-10-27 | 国立大学法人东京大学 | Detection chip and detection device |
-
2022
- 2022-03-31 WO PCT/JP2022/016675 patent/WO2022211058A1/en active Application Filing
- 2022-03-31 CN CN202280014739.0A patent/CN116867537A/en active Pending
- 2022-03-31 KR KR1020237026976A patent/KR20230163360A/en unknown
- 2022-03-31 JP JP2023511729A patent/JPWO2022211058A1/ja active Pending
- 2022-03-31 TW TW111112637A patent/TW202304546A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20230163360A (en) | 2023-11-30 |
CN116867537A (en) | 2023-10-10 |
JPWO2022211058A1 (en) | 2022-10-06 |
WO2022211058A1 (en) | 2022-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10029081B2 (en) | Molding compact, and manufacturing method for transdermal absorption sheet | |
EP3006078B1 (en) | Needle body manufacturing method | |
KR101594908B1 (en) | Method for producing transdermal patch and transdermal patch | |
KR101724655B1 (en) | Micro-needle patch and menufacturing method thereof | |
JP2020505081A (en) | System and method for manufacturing a microneedle device | |
TW201628586A (en) | Microneedle patch, method for manufacturing same, and apparatus for manufacturing microneedle array | |
US10596361B2 (en) | Transdermal absorption sheet and method of producing the same | |
JP5063543B2 (en) | Method for producing transdermal absorption sheet | |
US20210023355A1 (en) | Method of producing microneedle array, microneedle array, and microneedle array unit | |
KR101868872B1 (en) | Micro-needle and manufacturing method thereof | |
CN108939283B (en) | Human body safe degradable microneedle array and manufacturing method and mold thereof | |
JP2017104490A (en) | Micro structure production method | |
CN114917465B (en) | Self-heating microneedle drug-loaded patch and preparation method thereof | |
TW202304546A (en) | Microneedle structure production method and microneedle structure | |
WO2022211059A1 (en) | Microneedle structure and method for producing same | |
JP2022157925A (en) | Manufacturing method for microneedle structure | |
JP2003321350A (en) | Percutaneously absorbable preparation and method for percutaneously absorbing drug using the same | |
JP6398293B2 (en) | Acicular device | |
JP7141625B1 (en) | Microneedle patch and microneedle structure | |
TW202408614A (en) | microneedle structure | |
WO2023190910A1 (en) | Microneedle structure | |
JP2024049852A (en) | Method of manufacturing microneedle structure | |
KR102635701B1 (en) | Microneedle with drug storage space and manufacturing method thereof | |
JP2008188273A (en) | Medicine delivery device | |
CN115845241A (en) | Microneedle transdermal drug delivery device and preparation method thereof |